We seek equity investments from regional and/or global partners to co-develop our unique program through anticipated Phase II clinical trials. Please contact us to explore licensing and collaboration opportunities;
Prospective investors should direct inquiries to:
David R. Volk CEO CDG Therapeutics Inc.
Steven Fleck CFO CDG Therapeutics Inc.